Risk Minimization Measures for Blood Screening HIV-1 Nucleic Acid Amplification Technique Assays in Germany. - Wikidata - awgldk - TriplyDB

Risk Minimization Measures for Blood Screening HIV-1 Nucleic Acid Amplification Technique Assays in Germany.

Risk Minimization Measures for Blood Screening HIV-1 Nucleic Acid Amplification Technique Assays in Germany.

http://www.wikidata.org/entity/Q37630304

about

Automated Triplex (HBV, HCV and HIV) NAT Assay Systems for Blood Screening in India Implementation of an HIV-1 Triple-Target NAT Assay in the Routine Screening at Three German Red Cross Blood Centres.Human Immunodeficiency Virus (HIV).High sensitivity detection of HIV-1 using two genomic targets compared with single target PCR.Detection of emergent strains of West Nile virus with a blood screening assay.Evaluation of the Procleix Ultrio Elite Assay and the Panther-System for Individual NAT Screening of Blood, Hematopoietic Stem Cell, Tissue and Organ Donors.[Human immunodeficiency virus: position of Blood Working Group of the Federal Ministry of Health].Validation of new real-time polymerase chain reaction assays for detection of hepatitis A virus RNA and parvovirus B19 DNA.Knowledge Is Safety: The Time Is Ripe for Hepatitis E Virus Blood Donor Screening.

P2860

Q26752681-C6C24F7F-358C-49D4-9C46-49EDB9A9BFFB Q37045800-F88D3A9C-4DDC-4FB2-9B68-DE88B2EF5CB9 Q37045832-FD0CE6E6-F2BC-4C1D-AE44-B6548CD81A63 Q38295260-40BBDE57-9CD1-4EA3-9850-3FA0ED4ACB9C Q40127918-1EA5981A-9562-49AB-AC52-9252CB2CF6B2 Q40656078-A61CB836-E423-4AD2-A974-D1A6807F8038 Q40942917-A131646E-8C80-4AB8-9FB4-2822E0271F8B Q41008044-C0049D34-CF95-4EBC-8B83-4177776712B7 Q42351584-3B5321C9-68BD-4B52-8076-0FE6D2378516

P2860

Risk Minimization Measures for Blood Screening HIV-1 Nucleic Acid Amplification Technique Assays in Germany.

http://www.wikidata.org/entity/Q37630304

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 19 December 2013

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Risk Minimization Measures for ...... n Technique Assays in Germany.

@en

Risk Minimization Measures for ...... n Technique Assays in Germany.

@nl

type

label

Risk Minimization Measures for ...... n Technique Assays in Germany.

@en

Risk Minimization Measures for ...... n Technique Assays in Germany.

@nl

prefLabel

Risk Minimization Measures for ...... n Technique Assays in Germany.

@en

Risk Minimization Measures for ...... n Technique Assays in Germany.

@nl

P1433

Q37630304-2FC1F23A-6049-4854-B77C-070C7108646F

P1476

Q37630304-DFA11783-8535-4189-92AF-0EE6ADD52576

P2093

Q37630304-49FB9354-4C7C-45B4-8CB2-AE2F8CD6C546

Q37630304-4E53D753-32CA-41CA-A14E-8D19C73CAADD

Q37630304-60232409-245E-4D29-A55F-54FF224F5C21

Q37630304-7CC3E9D2-C640-4B82-BCB5-D12B06ED2F2A

Q37630304-C7F873AB-63C8-4C45-B794-0A127A45D585

Q37630304-F177A8D6-391C-4F6E-981A-CF9CBA1D692D

P2860

Q37630304-2859FFA1-B04D-4293-9B91-CAD5BF318E0A

Q37630304-29CC7801-676D-4E5B-9A03-F4DE3D80E027

Q37630304-3F330601-5B57-4334-A597-F37D4206AA52

Q37630304-41FEB420-1719-4BF8-94CC-6C26D8F32D14

Q37630304-4F2E179C-A6D2-4155-A220-53A0ED4DA815

Q37630304-6616D7CC-5886-4FCF-8562-B2895F0B9381

Q37630304-845FDCA1-C042-472B-812E-A4A4A59E99F2

Q37630304-8643B580-05CB-4E34-BD3A-1F209B62E720

Q37630304-909D1CD2-B4B7-47D1-91F8-1A50F6FD5412

Q37630304-9364E401-EAC0-4994-9DB0-A5FF7F71462F

P304

Q37630304-EA04AF8D-4876-49B6-94B5-DAA87AC42157

P31

Q37630304-A1C09851-29E0-4FE1-A1BA-FB43C1B00748

P356

Q37630304-BCD574C9-01D3-4280-8FF3-BECA74C460A5

P433

Q37630304-554CFBE5-3BDB-45DD-8890-5DF4C04E2EAE

P478

Q37630304-BE50C8ED-2763-4745-A541-8BC2FABA1E35

P577

Q37630304-7FFD54E0-789E-4DC6-BC3C-A70D29F00BB3

P5875

Q37630304-BE1200E0-975C-4DA4-9DA4-7C8161C285B4

P698

Q37630304-CF9736A1-F290-4A68-B424-2C70A401A0A1

P921

Q37630304-65BAA424-B0E7-4D95-A96B-5CD629DB7E19

Q37630304-71E993A3-0711-4B1F-AA5B-2C24FDA37115

P932

Q37630304-01E2462A-6F9D-4998-B8AD-C1907CE4CCF0

P356

P1433

Transfusion Medicine and Hemotherapy

P1476

Risk Minimization Measures for ...... n Technique Assays in Germany.

@en

P2093

C Micha Nübling

http://www.w3.org/2001/XMLSchema#string

Jochen Halbauer

http://www.w3.org/2001/XMLSchema#string

Julia Kress

http://www.w3.org/2001/XMLSchema#string

Margarethe Heiden

http://www.w3.org/2001/XMLSchema#string

Markus B Funk

http://www.w3.org/2001/XMLSchema#string

Michael Chudy

http://www.w3.org/2001/XMLSchema#string

P2860

Evaluation of the Roche Cobas AmpliPrep/Cobas TaqMan HIV-1 test and identification of rare polymorphisms potentially affecting assay performance

[HIV, HCV, HBV and syphilis surveillance among blood donors in Germany 2008-2010].

Single-point mutations causing more than 100-fold underestimation of human immunodeficiency virus type 1 (HIV-1) load with the Cobas TaqMan HIV-1 real-time PCR assay.

Impact of discrepancies between the Abbott realtime and cobas TaqMan assays for quantification of human immunodeficiency virus type 1 group M non-B subtypes.

Evaluation of an upgraded version of the Roche Cobas AmpliPrep/Cobas TaqMan HIV-1 test for HIV-1 load quantification.

First transmission of human immunodeficiency virus Type 1 by a cellular blood product after mandatory nucleic acid screening in Germany.

Human immunodeficiency virus type 1 (HIV-1) plasma load discrepancies between the Roche COBAS AMPLICOR HIV-1 MONITOR Version 1.5 and the Roche COBAS AmpliPrep/COBAS TaqMan HIV-1 assays.

Experience of mandatory nucleic acid test (NAT) screening across all blood organizations in Germany: NAT yield versus breakthrough transmissions.

Validation of HCV-NAT assays and experience with NAT application for blood screening in Germany.

Sensitivity of HCV core antigen and HCV RNA detection in the early infection phase.

P304

45-51

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1159/000357103

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

41

http://www.w3.org/2001/XMLSchema#string

P577

2013-12-19T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

261035501

http://www.w3.org/2001/XMLSchema#string

P698

24659947

http://www.w3.org/2001/XMLSchema#string

P921

P932

3949608

http://www.w3.org/2001/XMLSchema#string